KAVERI SEED COMPANY
|
KAVERI SEED COMPANY Last 5 Year Financial Ratios History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 54.69 | 58.08 | 48.59 | 36.43 | 51.47 |
| CEPS(Rs) | 62.62 | 63.74 | 52.43 | 40.08 | 55.27 |
| DPS(Rs) | 5.00 | 5.00 | 4.00 | 4.00 | 4.00 |
| Book NAV/Share(Rs) | 291.44 | 239.64 | 244.10 | 219.60 | 206.27 |
| Tax Rate(%) | 5.03 | 6.51 | 4.63 | 4.47 | 3.06 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 24.14 | 24.89 | 22.83 | 20.88 | 28.75 |
| EBIT Margin(%) | 24.68 | 27.95 | 26.73 | 22.98 | 31.03 |
| Pre Tax Margin(%) | 24.67 | 27.93 | 26.71 | 22.96 | 30.98 |
| PAT Margin (%) | 23.43 | 26.11 | 25.47 | 21.94 | 30.03 |
| Cash Profit Margin (%) | 26.73 | 28.55 | 27.39 | 24.10 | 32.18 |
| Performance Ratios | |||||
| ROA(%) | 11.77 | 14.30 | 13.59 | 10.88 | 17.28 |
| ROE(%) | 20.67 | 23.09 | 20.61 | 16.85 | 28.25 |
| ROCE(%) | 21.77 | 24.71 | 21.61 | 17.63 | 29.08 |
| Asset Turnover(x) | 0.50 | 0.55 | 0.53 | 0.50 | 0.58 |
| Sales/Fixed Asset(x) | 1.85 | 2.12 | 2.18 | 2.09 | 2.30 |
| Working Capital/Sales(x) | 1.26 | 1.54 | 1.14 | 1.05 | 1.13 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.54 | 0.47 | 0.46 | 0.48 | 0.43 |
| Receivable days | 30.94 | 38.96 | 41.61 | 40.71 | 39.39 |
| Inventory Days | 268.26 | 232.09 | 252.09 | 278.48 | 239.25 |
| Payable days | 279.62 | 193.88 | 186.30 | 248.25 | 255.93 |
| Valuation Parameters | |||||
| PER(x) | 23.10 | 10.73 | 9.81 | 15.00 | 9.98 |
| PCE(x) | 20.18 | 9.78 | 9.09 | 13.63 | 9.29 |
| Price/Book(x) | 4.34 | 2.60 | 1.95 | 2.49 | 2.49 |
| Yield(%) | 0.40 | 0.80 | 0.84 | 0.73 | 0.78 |
| EV/Net Sales(x) | 5.38 | 2.77 | 2.47 | 3.26 | 2.98 |
| EV/Core EBITDA(x) | 19.21 | 9.12 | 8.63 | 12.99 | 8.98 |
| EV/EBIT(x) | 21.78 | 9.91 | 9.25 | 14.21 | 9.60 |
| EV/CE(x) | 4.32 | 2.58 | 1.94 | 1.65 | 1.55 |
| M Cap / Sales | 5.39 | 2.79 | 2.49 | 3.28 | 2.99 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 4.93 | 7.29 | 10.35 | -6.40 | 11.39 |
| Core EBITDA Growth(%) | -3.38 | 13.83 | 25.77 | -29.08 | 15.05 |
| EBIT Growth(%) | -7.35 | 12.21 | 28.36 | -30.68 | 17.72 |
| PAT Growth(%) | -5.87 | 9.99 | 28.12 | -31.62 | 19.74 |
| EPS Growth(%) | -5.83 | 19.52 | 33.39 | -29.22 | 19.86 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | - | - | - | - | - |
| Current Ratio(x) | 1.87 | 1.95 | 2.43 | 2.67 | 2.35 |
| Quick Ratio(x) | 0.93 | 1.00 | 1.34 | 1.29 | 1.29 |
| Interest Cover(x) | 1,565.31 | 1,316.18 | 1,518.49 | 1,749.45 | 636.67 |
| Total Debt/Mcap(x) | - | - | - | - | - |
Compare Financial Ratios of peers of KAVERI SEED COMPANY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KAVERI SEED COMPANY | ₹6,141.8 Cr | 2.3% | 8.4% | 1.3% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹13,539.6 Cr | 3% | 6% | -26.7% | Stock Analytics | |
| VENKYS (INDIA) | ₹2,106.6 Cr | -1.3% | 6.9% | -34.6% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹1,404.9 Cr | -0.6% | 4% | -26.9% | Stock Analytics | |
| MANGALAM GLOBAL ENTERPRISE | ₹527.6 Cr | 1.4% | -2.4% | NA | Stock Analytics | |
| INDO US BIOTECH | ₹289.9 Cr | -2% | -9% | -56.5% | Stock Analytics | |
KAVERI SEED COMPANY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KAVERI SEED COMPANY | 2.3% |
8.4% |
1.3% |
| SENSEX | 1.6% |
2.3% |
1.1% |
You may also like the below Video Courses
